Buchumschlag

V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Shasha Jin, Tao Li, Liu Liu, Ting Gao, Tingting Zhang, Dingyi Yuan, Jianwen Di, Zhanying Guo, Zhijie Luo, Haoliang Yuan, Jun Liu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
von: Yali Gao, et al.
Veröffentlicht: (2026)

7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death
von: Hong Yang, et al.
Veröffentlicht: (2025)

Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin‐degrading enzyme, a new molecular vulnerability in multiple myeloma
von: Laetitia Lesire, et al.
Veröffentlicht: (2026)

The impact of Foxp3 + regulatory T‐cells on CD8 + T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors
von: Mikhaël Attias, et al.
Veröffentlicht: (2024)

Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis
von: Takahiro Sumimoto, et al.
Veröffentlicht: (2024)

Involvement of the somatosensory‐autonomic reflex and muscarinic receptors in exacerbation of allergic pulmonary inflammation by electroacupuncture
von: Shuyan Liu, et al.
Veröffentlicht: (2025)

Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration
von: Chen Xiao, et al.
Veröffentlicht: (2025)

Neutrophil extracellular traps drive tubulointerstitial fibrosis via the coiled‐coil domain‐containing protein 25 (CCDC25)–Yes‐associated protein 1 (YAP1) axis‐mediated autophagy regulation
von: Xinhui Hu, et al.
Veröffentlicht: (2026)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
von: Luping Liu, et al.
Veröffentlicht: (2026)

Kynurenic acid as a promising therapeutic agent in renal fibrosis: dual modulation of fibrosis and immune crosstalk
von: Sona Sykorova, et al.
Veröffentlicht: (2026)

Comparing the efficacy of efgartigimod and intravenous immunoglobulin on AQP4‐IgG‐positive neuromyelitis optica spectrum disorder during acute attacks
von: Jia Liu, et al.
Veröffentlicht: (2025)

Trained immunity: A link between risk factors and cardiovascular disease
von: Mingqi Chen, et al.
Veröffentlicht: (2024)

Preliminary efficacy and safety profile of dual histamine blockade on preventing filgrastim‐associated bone pain in breast cancer patients: Randomized controlled trial
von: Mona M. Eltamalawy, et al.
Veröffentlicht: (2025)

Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
von: Svetlana Obrenovic, et al.
Veröffentlicht: (2025)

SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐catenin
von: Lie Yuan, et al.
Veröffentlicht: (2025)

Microglial forkhead box O3a deficiency attenuates LPS‐induced neuro‐inflammation and depressive‐like behaviour through regulating the expression of peroxisome proliferator‐activated receptor‐γ
von: Rikang Wang, et al.
Veröffentlicht: (2024)

Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning
von: Sergio Corridore, et al.
Veröffentlicht: (2025)

CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8 + T cell‐ and NK cell‐dependent tumour immune escape
von: Fanglin Li, et al.
Veröffentlicht: (2026)

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses
von: De‐Kui Qiu, et al.
Veröffentlicht: (2026)

Sequential nephron blockade vs . sequential renin–angiotensin system blockade on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial
von: Juan Carlos Yugar‐Toledo, et al.
Veröffentlicht: (2026)

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies
von: Iek Leng Cheng, et al.
Veröffentlicht: (2025)

Sevoflurane acts as an antidepressant by suppression of GluN2D‐containing NMDA receptors on interneurons
von: Fei Guo, et al.
Veröffentlicht: (2024)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
von: Rolien Bosch, et al.
Veröffentlicht: (2024)

Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning
von: Dongxue Yan, et al.
Veröffentlicht: (2025)

A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
von: Marvin Xuejun Xu, et al.
Veröffentlicht: (2025)

Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
von: Isabel Werle, et al.
Veröffentlicht: (2024)

Synthesis and evaluation of a novel inhibitor for the α5‐GABA A receptor in the treatment of peripheral neuralgia: Evidence from MD simulation and in vivo studies
von: Yanming Chen, et al.
Veröffentlicht: (2025)

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor
von: Zoe Tasma, et al.
Veröffentlicht: (2024)

Opioid receptors in cardiovascular function
von: Venkatesh Katari, et al.
Veröffentlicht: (2025)

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects
von: James Goodman, et al.
Veröffentlicht: (2025)

A novel ryanodine receptor 2 inhibitor, M201‐A, enhances natriuresis, renal function and lusi‐inotropic actions: Preclinical and phase I study
von: Noboru Kaneko, et al.
Veröffentlicht: (2024)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
von: Marta Lopez‐Balastegui, et al.
Veröffentlicht: (2024)

A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye
von: Yiqin Dai, et al.
Veröffentlicht: (2024)

Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
von: Denise Pajonczyk, et al.
Veröffentlicht: (2024)

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease
von: Weicong Zhang, et al.
Veröffentlicht: (2024)

Chemistry/structural biology of psychedelic drugs and their receptor(s)
von: Ryan H. Gumpper, et al.
Veröffentlicht: (2024)

Infant deaths in the EudraVigilance database
von: David N. Juurlink, et al.
Veröffentlicht: (2026)

Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
von: Mingdian Tan, et al.
Veröffentlicht: (2025)

Ligustilide alleviates hepatic fibrosis by targeting the mesenchymal homeobox 1 (MEOX1)– transcriptional enhanced associate domain factor 2 (TEAD2) signalling axis
von: Qinrong Luan, et al.
Veröffentlicht: (2026)

The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors
von: Stephen P. H. Alexander, et al.
Veröffentlicht: (2025)